Procedural Sedation Completed Phase 2 Trials for Midazolam (DB00683)

IndicationStatusPhase
DBCOND0034835 (Procedural Sedation)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00869440Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI EndoscopyTreatment